Congratulations on the secondary. Obviously the market likes your story. Being gun shy the day MDXG fell below $2 wasn't one of my smarter moves.
And thank you OSIR for the camaraderie and the (loser) Turbo 911.
Now off to SPIHF, DSNY and XXII. All could quadruple within 2 years. And like with MDXG I could be proven wrong.
The neighborhood is becoming more contentious. A down day/month will do that. Three up and three down. All for an honest opinion from a longtime Osiris stalwart.
Suggestion: Instead of true/false try a short paragraph detailing why you agree or disagree. In other words your thoughts .....those of you that are still capable.
They were getting their paperwork organized when I visited Vancouver in October. They were addressing some corporate governance issues but expressed the opinion that these could easily be remedied. The days above $2 was going nicely until a recent dip. My reading is that this is not a hard and fast requisite for uplisting as short manipulators know how to leave a stock at $1.99.
So my take is that progress is being made and they realize this is an important step for the company. Recall that Steve and employees own a large chunk of the shares themselves.
Good question. MDXG flat on a secondary and OSIR hammered. Coincidence? Disquieting as it may be the market may be aligning itself with the view that Epifix may limit the success of Grafix in the marketplace. Yes I know about Ovation and Cartiform but today's issue is about wound treatments. Also the lingering worry regarding cost containment can't be helping.
There goes the no deal argument. Must be a poor deal then. What's left?
Must mean IOC is worth more than $3.6B. Bonk can that be right?
Today was likely the bottom. CEO issue settled along with company direction, Mesoblast $ and partnership, CMS fears put to rest and MMs ran the stops followed by a good bounce on substantial volume. Only good news ahead, finances in order and product offerings and sales force increasing.
What's not to like?
Forgot.... a lot of shorts have failed to cover although I'll bet some did today... or wish they had.
"ensures Grafix will be a commercial failure". Do you know what a non sequitur is? Know what stupid look like? Bet you do. Look in the mirror.
My guess is that Prochymal was Randy's baby and with it jettisoned Randy was not the best fit for a company that is now completely biosurgery.
Good luck Randy. You are a fine man and superb scientist. I regret the loss of Prochymal too.
Ensures Grafix will be a failure. Really Jason. I say it ensures Grafix will be a success. So there.
I know Jason, your crystal ball is bigger than mine, better optics no less.
Liked your clairvoyance with Neuralstem NVIV. Remember that bad crystal day. Shattered. I do and so do many of you acolytes.
Oh good for you. You must have read my posts on MDXG. They don't seem to fully appreciate my humor there. And I still find OSIR a very sound investment (and just love the guys on the board having been together in the trenches for so so long) but feel OSIR will be a triple as DSNY, XXII and SPIHF will be AT LEAST 10 baggers in the same time period.
For lots more info see iHub.
Now about that 911....
Not one cent margined. Account likely to reach 8 figures this year...... before the decimal point.
Selling the 911s for 60k. Interested....I'll invest it in MDXG.
Happy Thanksgiving tipsy.